US futures plunge along with global markets as the dollar feels the pressure of Yellens' dovish remarks on future interest rake hikes. Gold soars as investors jump into the safe haven metal. Overnight, crude dropped below $27 further pressuring the markets around the world. The 10 year Treasury yield is lower by 10 basis points to 1.57%. Later today Yellen will continue her testimony before Congress as all ears will listen for further confirmation of rate hike possibilities.
NEWS:
- AMZN: announces $5B buyback authorization
- LMT: Pentagon looks to reach $15B deal for F-35s in March
- NVS: Sandoz announces EMA approves MAA for biosimilar pegfilgrastim
- INCY: halts late stage development of Jakafi for solid tumors after an interim analysis failed to show sufficient efficacy
- DDD: announces preliminary earnings: expects Q4 revenue of $183M vs consensus estimate of $161M
- BA: Boeing under investigate by the SEC regarding accounting for its 787 Dreamliner and 747 jets
- ILMN: Illumina enters bioinformatics partnership with Geomics England
- 8:30AM: Weekly Jobless Claims
- 9:45AM: Bloomberg Consumer Comfort Index
- 10AM: Yellen's Congressional Testimony on Monetary Policy
- 10:30AM: EIA Natural Gas Inventory
- 1PM: $16B 30 Year Note Auction
- 4:30PM: Money Supply and Fed Balance Sheet
- WFM: FQ1 EPS of $0.46 beats by $0.06: revenue of $4.83B beats by $20M: revenue +3.4% y/y: guides FY16 revenue +3%-5%
- CSCO: FQ2EPS of $0.57 beats by $0.03: revenue of $11.93B beats by $170M: revenue -0.1% y/y: guides in-line: announces additional $15B to buyback: raises dividend
- PXD: Q4 EPS of -$0.18 beats by $0.12: revenue of $1.07B beats by $251.51M: revenue -35.9% y/y: lowers FY16 capital budge to $2B
- EXPE: Q4 EPS of $0.77 misses by $0.23: revenue of $1.7B misses by $10M: revenue +25.0% y/y: Q4 gross bookings +40% y/y: guides FY16 EPITDA growth 35%-40% y/y
- TSLA: Q4 EPS of -$0.87 misses by $0.99: revenue of $1.75B misses by $50M: revenue +59.1% y/y: guides delivery of 16K vehicles in Q1: guides delivery of 80K-90K vehicles in FY16
- FRU: Q4 EPS of $1.94 misses by $0.36: revenue of $13.25B beats by $1.72B: revenue -16.3% y/y
- MYL: Q4 EPS of $1.22 misses by $0.05: revenue of $2.5B misses by $200M: revenue +20.2% y/y: guides FY16 adjusted EPS of $4.85-$5.15 vs consensu $4.97
- TWTR: Q4 EPS of $0.16 beats by $0.04: revenue of $710M in-line: revenue +48.2% y/y: guides Q1 revenue $595M-$610M vs consensus $629.25M
- CNO: Q4 EPS of $0.52 beats by $0.15: revenue of $969.6M misses by $19.95M: revenue -3.0% y/y
- EFX: Q4 EPS of $1.14 beats by $0.03: revenue of $666.3M beats by $3.92M: revenue +6.7% y/y: guides revenue above consensus
- CTL: Q4 EPS of $0.80 beats by $0.15: revenue of $4.48B beats by $60M: revenue +0.9% y/y: guides FY16 adjusted EPS $2.50-$2.70 vs consensus $2.36
- SKX: Q4 EPS of $0.19 misses by $0.01: revenue of $722.68 beats by $29.2M: revenue +26.8% y/y: guides in-line
- ZNGA: Q4 EPS of $0.00 in-line: revenue of $182.1M beats by $3.43M: revenue -0.1% y/y
- IRBT: Q4 EPS of $0.60 beats by $0.04: revenue of $206.42M beats by $4.17M: revenue +29.5% y/y: guides FY16 EPS of $1.20-$1.40 vs consensus $1.64
- MKL:Q4 EPS of $14.14 beats by $6.93: revenue of $1.42B beats by $90M: revenue +6.0% y/y
- IFF: Q4 EPS of $1.05 misses by $0.10: revenue of $715.65M misses by $31.41M: revenue -5.3% y/y: guides FY16 revenue up 6.5%-8.5%
- CSRA: Q4 EPS of $0.48 beats by $0.06: revenue of $1.27B misses by $50M: revenue -5.2% y/y: provides mixed guidance
- PPC: Q4 EPS of $0.26 misses by $0.14: revenue of $1.96B misses by $30M: revenue -7.1% y/y
- ORLY: Q4 EPS of $2.19 beats by $0.11: revenue of $1.95B beats by $40M: revenue +10.8% y/y
- PEP: Q4 EPS of $1.06 in-line: revenue of $18.59B beats by $80M: revenue -6.8% y/y: guides FY16 core EPS $4.66 vs consensus $4.76: raises annual dividend $0.20/share
- SON: Q4 EPS of $0.64 beats by $0.02: revenue of $1.27B misses by $10M: revenue -3.8% y/y: guides FY16 EPS $2.64-$2.74 vs consensus $2.69
- MOS: Q4 EPS of $0.53 beats by $0.09: revenue of $2.16B beats by $230M: revenue -9.2% y/y: announces $75M accelerated share repurchase authorization
- ALLE: Q4 EPS of $0.89 beats by $0.15: revenue of $545.4M misses by $16.05M: revenue -4.9% y/y: guides adjusted EPS $3.25-$3.40 vs consensus $3.38
- TU: Q4 EPS of C$0.54 beats by C$0.07: revenue of C$3.22B misses by C$30M: revenue +2.9% y/y: guides FY16 EPS C$2.40-C$2.56 vs consensus C$2.20 FY15: eyes 10% dividend hike in 2016
- TRIP: Q4 EPS of $0.45 beats by $0.12: Revenue of $309M beats by $10.46M: revenue +7.3% y/y
- Q: Q4 EPS of $0.90 beats by $0.03: revenue of $1.13B in-line: revenue +6.6% y/y:guides FY16 adjusted EPS $3.70-$3.85 vs consensus $3.70
- GRA: Q4 EPS of $1.40 beats by $0.08: revenue of $758.7M misses by $31.27M: revenue -5.6% y/y: guides FY16 adjusted EPS $3.02-$3.21 vs consensus $3.14
- NOK: Q4 EPS of €0.15 beats by €0.03: revenue of €3.6B misses by €280M: revenue +2.9% y/y: announces that the board is considering a special dividend
- TRI: Q4 EPS of $0.65 beats by $0.07: revenue of $3.15B misses by $20M: revenue -1.9% y/y: guides FY16 revenue growth in low single digits
- BG: Q4 EPS of $1.40 misses by $0.10: revenue of $11.13B misses by $720M: revenue -15.9% y/y
- TIME: Q4 EPS of $0.58 misses by $0.08: revenue of $877M beats by $4.19M: revenue -2.0% y/y: guides revenue above consensus
- TAP: Q4 EPS of $0.49 misses by $0.01: revenue of $844.4M in-line: revenue -13.3% y/y
- GNC: Q4 EPS of $0.63 beats by $0.01: revenue of $618.2M misses by $3.01M: revenue +1.8% y/y: guides: FY15 EPS $3.15-$3.35 vs consensus $3.19
- AVP: Q4 EPS of $0.00 misses by $0.08: revenue of $1.61B msses by $210M: revenue -19.9% y/y
- PBF: Q4 EPS of $0.70 beats by $0.07: revenue of $3.36B misses by $130M: revenue -25.7% y/y
- HUN: Q4 EPS of $0.51 beats by $0.29: revenue of $2.33B misses by $100M: revenue -21.0% y/y
- PNK: Q4 EPS of $0.40 misses by $0.02: revenue of $558.42M misses by $3.21M: revenue +0.7% y/y
- NILE: Q4 EPS of $0.43 in-line: revenue of $150M misses by $14.54M; revenue -4.7% y/y: soft guidance
- AAP: Q4 EPS Of $1.22 beats by $0.01: revenue of $2.03B misses by $20M: revenue -9.4% y/y
- NLSN: Q4 EPS of $0.82 beats by $0.02: revenue of $1.62B beats by $10M: revenue -0.6% y/y
- K: Q4 EPS of $0.79 beats by $0.04: revenue $3.12B misses by $40M: revenue -6.0% y/y
- AIG, ATVI, BCOR, CBS, COLM, CRAY, CYBR, DDR, DNB, DVA, EGN, FEYE, GRPN, GUID, HE, INFN, KN, LOGM, NBIX, NUS, NUVA, P, PDFS, QLIK, ROVI, RSG, SCSS, SSNC, TRUP, VRNS, VRSN, WYNN
UPGRADES:
- VOYA: upgrade: underweight to neutral: JP Morgan: pt cut from $45 to $41
- TEN: upgrade: equal weight to overweight: Barclays
- ULTA: upgrade: outperform to strong buy: Raymond James: pt cut from $205 to $188
- ASNA: upgrade: sell to neutral: Goldman Sachs: $7
- FDC: upgrade: neutral to outperform: Credit Suisse: pt cut from $20 to $12
- LVLT: upgrade: equal weight to overweight: Morgan Stanley: $60
- APAM: upgrade: sell to neutral: Citi
- OHI: upgrade: market perform to outperform: JMP Securities: $31
- CSCO: upgrade: hold to buy: Jefferies: pt raised from $26 to $27.50
- HMN: upgrade: neutral to buy: Janney Capital
- WAL: upgrade: neutral to buy: DA Davdison: $37
- OHI: upgrade: market perform to outperform: JMP Securities: $31
- TWX: upgrade: buy to conviction buy: Goldman: pt cut from $83 to $80
- SKT: upgrade: neutral to buy: Hilliard Lyons
- WAL: upgrade: neutral to buy: DA Davidson: $37
- CHRW: upgrade: neutral to buy: Buckingham: pt raised from $63 to $80
- TWTR: downgrade: overweight to equal weight: Barclays: $19
- TWTR: downgrade: buy to hold: Topeka Capital: pt cut from $35 to $15
- RUN: downgrade: overweight to equal weight: Barclays: $7
- SCTY: downgrade: overweight to equal weight: Barclays: pt cut from $49 to $20
- CSTE: downgrade: overweight to equal weight: Barclays: $38
- WEN: downgrade: buy to neutral: JP Morgan: $10.50
- SNV: downgrade: market perform to underperform: Morgan Stanley: $29
- RF: downgrade: overweight to equal weight: Morgan Stanley: $9
- HCP: downgrade: hold to sell: Stifel: $23
- ARMH: downgrade: market perform to underperform: Bernstein
- FLO: downgrade: buy to neutral: SunTrust: pt cut from $30 to $20
- PSEC: downgrade: market perform to underperform: Raymond James
- DFS: downgrade: buy to neutral: BofA/Merrill: pt cut from $60 to $48
- COF: downgrade: buy to neutral: BofA/Merrill: $66
- MA: downgrade: buy to neutral: BofA/Merrill: pt cut from $105 to $92
- V: downgrade: buy to neutral: BofA/Merrill: $75
- SEMI: downgrade: neutral to sell: Citi
- IFF: downgrade: buy to hold: Deutsche Bank
- BID: downgrade: buy to hold: Stifel
- DEI: downgrade: hold to sell: Stifel: $23.50
- SQ: initiated: neutral: SunTrust: $9
- GILD: initiated: outperform: Oppenheimer: $120
- EL: initiated: overweight: Atlantic Equities: $102
- AXTA: pt raised from $31 to $32: RBC Capital
- O: pt raised from $56 to $66: Oppenheimer
- ZNGA: pt cut from $3 to $2.50: Piper Jaffray
- WIX: pt cut from $36 to $35: RBC Capital
- VOYA: pt cut from $53 to $46: RBC Capital
- UDR: pt cut from $38 to $37: RBC Capital
- TWTR: pt cut from $34 to $23: RBC Capital
- TWTR: pt cut from $21 to $15: Mizuho
- TSLA: pt cut from $240 to $180: RBC Capital
- TSLA: pt cut from $180 to $155: JP Morgan
- TSLA: pt cut from $325 to $240: Credit Suisse
- PRU: pt cut from $91 to $80: RBC Capital
- PXD: pt cut from $175 to $165: Topeka Capital
- NTAP: pt cut from $28 to $26: RBC Capital
- EXPE: pt cut from $180 to $165: RBC Capital
- CAH: pt cut from $105 to $85: RBC Capital
- PAA: pt cut from $23 to $19: RBC Capital
- HDP: pt cut from $25 to $18: Mizuho
- HDP: pt cut from $36 to $17: Wunderlich
- FDC: pt cut from $20 to $17: Mizuho
- CSOD: pt cut from $42 to $34: FBR Capital
- NGL: pt cut from $15. to $7.50: Wunderlich
- HUBS: pt cut from $68 to $46: UBS
- TYL: pt cut from $219 to $211: Maxim Group
- FSFR: pt cut from $11 to $9: Maxim Group
- INCY: pt cut from $125 to $65: RBC Capital

No comments:
Post a Comment